There is increasing attention in the field of Alzheimer’s disease research to identify the disease process
at its earliest point. Biomarkers that characterize the disease are now available such that a person can be
identified even when the person may be cognitively normal. The motivation for early identification is
that early intervention would likely reduce the impact of the disease or even possibly prevent it. We will
discuss the current state of the art for clinical diagnosis using biomarkers to identify early features of the
disease. It is anticipated that disease modifying therapies will be available in the near future.
Ronald C. Petersen, Ph.D., M.D.
Professor of Neurology
Cora Kanow Professor of Alzheimer’s Disease Research
Director, Mayo Alzheimer’s Disease Research Center
Mayo Clinic College of Medicine
Dr. Ronald C. Petersen received a Ph.D. in Experimental Psychology from the University of Minnesota and graduated from Mayo Medical School in 1980. He completed an internship in Medicine at Stanford University Medical Center and returned to the Mayo Clinic to complete a residency in Neurology. That was followed by a fellowship in Behavioral Neurology at Harvard University Medical School/Beth Israel Hospital in Boston, Massachusetts. Dr. Petersen joined the staff of the Mayo Clinic in 1986 and rose through the ranks to become a Professor of Neurology in 1996. In 2000 he was named the Cora Kanow Professor of Alzheimer’s Disease Research and Mayo Clinic Distinguished Investigator in 2011.
He is currently the Director of the Mayo Alzheimer’s Disease Research Center and the Mayo Clinic Study of Aging and has authored over 800 peer-reviewed articles on memory disorders, aging, and Alzheimer’s disease. He has edited five books, Memory Disorders, Mayo Clinic on Alzheimer’s Disease, Mild Cognitive Impairment: Aging to Alzheimer’s Disease, Mayo Clinic Guide to Alzheimer’s Disease and Mayo Clinic on Alzheimer’s Disease (2013).
Dr. Petersen is one of the recipients of the 2004 MetLife Award for Medical Research in Alzheimer’s Disease and the 2005 Potamkin Prize for Research in Picks, Alzheimer’s and Related Disorders of the American Academy of Neurology. Dr. Petersen also received the inaugural Ronald and Nancy Reagan Research Institute Award in 2004 from the Alzheimer’s Association and the inaugural Leon Thal Prize of the Lou Ruvo Brain Institute in 2007. In 2012 he received the Khachaturian Award of the Alzheimer’s Association and the Henry Wisniewski Lifetime Achievement Award in 2013. In 2011 he was appointed by the Secretary of Health and Human Services to serve as the Chair of the Advisory Committee on Research, Care and Services for the National Alzheimer’s Project Act. Recently, he was appointed to the World Dementia Council by the UK government.